Roche Xenical
Executive Summary
U.S. prescriptions for the anti-obesity agent orlistat totaled 96,485 in its first four weeks on the market, IMS Health reported. For the week ending May 21, 73% of Xenical prescriptions were paid for in cash and 27% were covered by a third party payer, compared to an industry average of 67% third party coverage